This study addresses the contributions of speci®c retinoid receptors during all-trans-retinoic acid (RA)-mediated dierentiation and growth suppression of human embryonal carcinoma cells. The pleiotropic eects of RA are mediated by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), members of the nuclear receptor family of transcription factors. After RA-treatment the multipotent human embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) displays limited proliferative potential, reduced tumorigenicity, and morphologic and immunophenotypic neuronal maturation. RARg over-expression in NT2/D1 cells signals mesenchymal NT2/D1 terminal dierentiation while RARa and RARb do not and RARg overcomes retinoid resistance in an NT2/D1 clone (NT2/D1-R1) having deregulated RARg expression. Since RARg transfectants do not display neuronal maturation, this study sought to identify cooperating retinoid receptors engaged in NT2/D1 dierentiation. Through gain of function experiments, this report highlights RXRb as playing an important role along with RARg in signaling dierentiation of NT2/D1 cells. Stable over-expression of RXRb, but not RXRa or RXRg, was found to signal NT2/D1 growth suppression and to induce a non-neuronal morphology and immunophenotype. Notably, co-transfection of RARg and RXRb resulted in marked growth suppression and for the ®rst time, expression of typical neuronal markers of NT2/D1 dierentiation. To clarify the role of RXRb and RARg in this dierentiation program, a modi®ed transient ®broblast growth factor-4 (FGF4) promoter-enhancer reporter assay that re¯ects eective RA-mediated dierentiation of NT2/D1 cells was employed. Transfection of RARg or RXRb in NT2/D1 cells augments transcriptional repression of the FGF4 reporter and RARg and RXRb co-transfection markedly repressed reporter activity, indicating the combined role of these receptors in RA-induced NT2/D1 dierentiation. Taken together, these ®ndings reveal speci®c retinoid receptors must cooperate to signal terminal growth suppression and maturation of NT2/D1 cells. Since the transcriptional repression of FGF4 is coupled to the eective maturation of human embryonal carcinoma cells, the described co-transfection strategy should prove useful to identify genes with positive or negative eects on the dierentiation program of these tumor cells.
This study addresses the contributions of speci®c retinoid receptors during all-trans-retinoic acid (RA)-mediated dierentiation and growth suppression of human embryonal carcinoma cells. The pleiotropic eects of RA are mediated by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), members of the nuclear receptor family of transcription factors. After RA-treatment the multipotent human embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) displays limited proliferative potential, reduced tumorigenicity, and morphologic and immunophenotypic neuronal maturation. RARg over-expression in NT2/D1 cells signals mesenchymal NT2/D1 terminal dierentiation while RARa and RARb do not and RARg overcomes retinoid resistance in an NT2/D1 clone (NT2/D1-R1) having deregulated RARg expression. Since RARg transfectants do not display neuronal maturation, this study sought to identify cooperating retinoid receptors engaged in NT2/D1 dierentiation. Through gain of function experiments, this report highlights RXRb as playing an important role along with RARg in signaling dierentiation of NT2/D1 cells. Stable over-expression of RXRb, but not RXRa or RXRg, was found to signal NT2/D1 growth suppression and to induce a non-neuronal morphology and immunophenotype. Notably, co-transfection of RARg and RXRb resulted in marked growth suppression and for the ®rst time, expression of typical neuronal markers of NT2/D1 dierentiation. To clarify the role of RXRb and RARg in this dierentiation program, a modi®ed transient ®broblast growth factor-4 (FGF4) promoter-enhancer reporter assay that re¯ects eective RA-mediated dierentiation of NT2/D1 cells was employed. Transfection of RARg or RXRb in NT2/D1 cells augments transcriptional repression of the FGF4 reporter and RARg and RXRb co-transfection markedly repressed reporter activity, indicating the combined role of these receptors in RA-induced NT2/D1 dierentiation. Taken together, these ®ndings reveal speci®c retinoid receptors must cooperate to signal terminal growth suppression and maturation of NT2/D1 cells. Since the transcripIntroduction Retinoids are derivatives of vitamin A and exert potent growth and dierentiation eects on normal, embryonic and neoplastic cells (reviewed in Sporn et al., 1994) . Bene®cial clinical eects of the retinoids are observed in malignant and pre-malignant cells. For example, retinoids are active in the treatment of the premalignant lesion, oral leukoplakia and reduce incidence of second head and neck, lung and hepatocellar carcinomas (Hong et al., 1986 (Hong et al., , 1990 Pastorino et al., 1993; Muto et al., 1996) . All-trans-retinoic acid (RA) also induces transient complete remissions in acute promyelocytic leukemia (APL) (Warrell et al., 1991; Castaigne et al., 1990; Huang et al., 1988) . This clinical response is linked to the signaling of leukemic cell maturation and to expression of the t(15,17) translocation product PML/RARa (Miller et al., 1992) . Human and murine embryonal carcinoma cells are useful models to study the mechanisms of RA-mediated terminal dierentiation of tumor cells. In these models, RA-mediated terminal dierentiation is linked to changes in expression of diverse genes (Simeone et al., 1990; Miller et al., 1990; Bouillet et al., 1995) . Few of these changes in gene expression are likely required for tumor cell maturation to proceed, but play a coincident and not a causal role in signaling the dierentiation program. There is a need to identify those genes required to initiate and sustain the maturation signal of dierentiation agents such as RA.
The biologic eects of retinoids are initiated through transcriptional activation of two families of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs) (reviewed in Mangelsdorf et al., 1994; Chambon, 1996) . In addition to analysis of nuclear receptors with known ligands, an important role for orphan nuclear receptors in signaling growth suppression and dierentiation is emerging (Mangelsdorf and Evans, 1995) . RA activates RARs while 9-cis retinoic acid is a bifunctional ligand activating both RAR and RXR pathways (Mangelsdorf et al., 1994; Chambon, 1996) . Retinoid mediated changes in gene expression occur by the binding of RAR/RXR heterodimers or RXR/RXR homodimers to de®ned response elements contained within target genes (Mangelsdorf et al., 1991; Nagpal et al., 1992) . Recently, co-activators and co-repressors were shown to associate with retinoid receptors in a ligand-dependent fashion (Chen and Evans, 1995; Kurokawa et al., 1995; Onate et al., 1995; Chakravarti et al., 1996) . These factors may interact with the basal machinery responsible for transcription (Glass et al., 1997) . Three RARs (RARa, RARb and RARg) and three RXRs (RXRa, RXRb and RXRg) exist and have cell context dependent expression patterns re¯ecting tissue-speci®c retinoid functions and developmental programs (DolleÂ et al., 1990; Leid et al., 1992a) . Multiple retinoid receptor isoforms result from alternative splicing and dual promoter usage (Leid et al., 1992a) . Defects reminiscent of vitamin A de®ciency observed when RAR and RXR homozygous deleted mice are crossed support an important role for RXR as a heterodimeric partner for RAR during development (Kastner et al., 1997) . Studies with RAR and RXR selective ligands also support a key role of heterodimers in mediating RA signals (Lotan et al., 1995; Roy et al., 1995; Minucci et al., 1997; Horn et al., 1996) .
The apparent multiplicity of the retinoid pathway raises questions about the speci®c roles of individual receptors in retinoid signaling. In vitro studies indicate that RXRs and RARs dierentially activate various RA-responsive elements (RAREs) (Nagpal et al., 1992; La Vista-Picard et al., 1996) . A recent report using murine F9 embryonal carcinoma cells demonstrates that distinct RAR/RXR heterodimers dierentially regulate the expression of established retinoid responsive genes (Chiba et al., 1997) . This ®nding suggests within a given cell context, distinct retinoid receptor dimers activate or repress`down-stream' regulators which mediate retinoid phenotypic eects.
This report comprehensively investigates through gain of function experiments, the role of RARs and RXRs in mediating RA-induced signals that trigger terminal growth suppression and maturation of the multipotent human embryonal carcinoma cell line NTERA-2/clone D1 (designated NT2/D1). After RAtreatment, these cells have limited proliferative potential, reduced tumorigenicity, and develop morphologic and immunophenotypic neuronal maturation (Andrews, 1984; Miller et al., 1994) . Our prior work reveals that RA-treatment induces expression of all three RARs (Moasser et al., 1995 (Moasser et al., , 1996 . RARg mediates many biologic eects of RA in these cells. Over-expression of RARg, but not RARa or RARb, results in growth suppression and maturation of NT2/ D1 cells to a mesenchymal and not to a neuronal phenotype (Moasser et al., 1995) . Derived RA-resistant NT2/D1 lines and de novo retinoid-resistant embryonal carcinoma cells fail to induce RARg expression despite RA-treatment (Moasser et al., 1994 (Moasser et al., , 1996 . Notably, over-expression of RARg alone is insucient to induce the neuronal phenotype seen when NT2/D1 cells are treated with optimal retinoid dosages, suggesting factors in addition to RARg are required to signal NT2/D1 dierentiation.
This report investigates the function of potential RARg heterodimeric partners (RXRa, RXRb and RXRg) to signal full RA responses in these tumor cells. Using a previously described selection strategy of episomal vector-based over-expression of retinoid receptors, RXRb, but not RXRa or RXRg, is now shown to signal NT2/D1 growth suppression and to induce a non-neuronal morphology and immunophenotype. Notably, co-transfection of RARg and RXRb results in marked growth suppression and for the ®rst time, expression of typical neuronal markers of NT2/ D1 dierentiation. It is also reported here that RARg and RXRb cooperate to repress transcription in a modi®ed FGF4 promoter-enhancer reporter assay that re¯ects eective RA-mediated dierentiation of NT2/ D1 cells. This assay should prove useful to assess the activity of candidate target genes which trigger retinoid response in human embryonal carcinoma cells. The ®ndings presented demonstrate that speci®c retinoid receptors signal terminal growth suppression and maturation of these tumor cells. Cooperation between speci®c RAR and RXR family members is needed to eciently signal terminal dierentiation of these human embryonal cancer cells.
Results

RXRb over-expression in NT2/D1 cells
Over-expression of RARg in NT2/D1 cells mediates growth suppression and mesenchymal maturation (Moasser et al., 1995) . In contrast, acute RAtreatment of NT2/D1 cells results in a neuronal phenotype and a more prominent growth suppression (Andrews, 1984; Miller et al., 1994) . To begin to identity transcription factors in addition to RARg that are engaged in RA-mediated maturation, RXRs were over-expressed in NT2/D1 cells using episomal-based transfection and a previously described selection strategy using the Eboplpp (Ebo) expression vector (Moasser et al., 1995) . NT2/D1 cells were previously transfected with Ebo-RXRa (Moasser et al., 1995) and results were extended in this study to Ebo-RXRb and Ebo-RXRg transfectants which were subjected to a two-phase selection strategy using hygromycin B. This strategy was successful in over-expressing potential growth suppressive species in diverse cell contexts including human embryonal carcinoma cells, transformed human bronchial epithelial cells and APL cells (Moasser et al., 1995; Ahn et al., 1995a,b) . The results of these transfection experiments are summarized in Figure 1 .
As depicted in Figure 1 , cells were gradually selected in 20 mg/ml hygromycin B for up to 8 weeks to Schema of the episomal vector selection procedure used to reveal the preferential growth inhibitory function of RXRb over-expression in NT2/D1 cells. The indicated Eboplpp (Ebo) episomal vector-based constructs were transfected into NT2/D1 cells and passaged for up to 8 weeks in low dosage (20 mg/ml) of hygromycin B. When selection was completed, the dosage of hygromycin B was escalated to up to 500 mg/ml. The RXRb but not RXRa or RXRg or insertless control transfectants suppress growth and trigger morphologic maturation. Repeated dose escalation of RXRb transfectants previously maintained at low doses of hygromycin B yielded similar results. These studies were conducted in the presence of serum minimize cellular plasmid copy number present in these transfectants (Moasser et al., 1995) . Untransfected cells failed to survive at this dosage and for this duration of selection. After the ®rst phase of selection, transfectants were subjected to up to 500 mg/ml hygromycin B, previously shown to increase the expression of episomal vector derived cDNAs in NT2/D1 cells (Moasser et al., 1995) . While cells transfected with the insertless vector, RXRa, or RXRg continued to proliferate without phenotypic or morphologic maturation, Ebo-RXRb transfectants growth arrested and exhibited morphologic maturation approximately 8 weeks after hygromycin dose escalation (see Table 1 ). Ebo-RXRa and Ebo-RXRg transfectants can be grown inde®nitely under these conditions. Observed eects after exposure to the higher hygromycin B dosage were due to increased RXRb expression (Figure 2a) . The RXRa transfected cell line was previously characterized and shown to express high levels of exogenous RXRa mRNA (Moasser et al., 1995) . RT ± PCR analysis of RXRg transfectants con®rmed abundant expression of exogenous RXRg (data not shown). The eect on cellular growth was quanti®ed by a MTT proliferation assay measured 2 weeks post-hygromycin B dosage escalation ( Figure 2b ). While control cells could be continuously passaged under these culture conditions, Ebo-RXRb cells ceased to proliferate after approximately 8 weeks of culture at the higher hygromycin B dosage.
Immunophenotype of RXRb NT2/D1 transfectants
The morphologic changes mediated by over-expression of RXRb were further characterized by monitoring expression of established immunophenotypic differentiation markers for NT2/D1 ( Figure 2c ). As previously described, RA-treatment of NT2/D1 cells resulted in increased expression of the established neuroectodermal marker, A2B5 and decreased expression of the marker of undierentiated NT2/D1 cells, the stage speci®c embryonic antigen-3 (SSEA3). Transfection with the Ebo insertless vector did not appreciably alter the basal and induced expression pattern of these markers after 5 days RA treatment when compared to parental NT2/D1 cells (data not shown and Figure 2c ). RXRb over-expressing NT2/D1 cells assayed 4 ± 6 weeks after hygromycin dose escalation exhibited decreased expression of SSEA3 without increased expression of A2B5, suggesting a shift to a more dierentiated, but to a non-neuronal phenotype. The basal and RA-treated immunophenotypic analysis of RXRa and RXRg transfectants were indistinguishable from that of parental NT2/D1 cells (data not shown).
RARg and RXRb expression in NT2/D1 versus NT2/ D1-R1 cells
Since over-expression of RXRb mediated growth suppression of NT2/D1 cells, the endogenous levels Total cellular RNA from NT2/D1 cells transfected with RXRb before (lane 1; 20 mg/ml) and after (lane 2; 500 mg/ml) selection with hygromycin B was hybridized to a cDNA probe for human RXRb. Lane 3 represents total RNA from NT2/D1 cells transfected with an insertless control vector and maintained at the 500 mg/ml hygromycin B dosage. The 28s ribosomal bands (rRNA) are displayed to con®rm comparable loading. (b) The MTT proliferation assay was performed using NT2/D1 cells transfected with an insertless control episomal vector (Ebo) or the vector containing the full length RXRb cDNA (Ebo-RXRb). These transfectants were passaged for 2 weeks in 500 mg/ml hygromycin B prior to performing this assay. (c) Florescence activated cell sorter (FACS) immunophenotypic analysis of NT2/ D1 cells transfected with RXRb (Ebo-RXRb) or insertless control vector (Ebo) before and after exogenous RA-treatment. The percentages of cells staining for the cell surface immunophenotypic markers A2B5 and SSEA3 were measured as described in Material and methods of RXRb in the absence and presence of RA were studied. Whole cell lysates were obtained before and after RA-treatment. Western analysis for expression of retinoid receptors was performed (Figure 3 ). Consistent with prior Northern analysis showing the induction of RARg mRNA expression in NT2/D1 but not its derived RA-resistant clone, NT2/D1-R1 (Moasser et al., 1994 (Moasser et al., , 1996 , RARg protein is now shown to be induced after RA-treatment of NT2/D1 but not NT2/ D1-R1 cells. NT2/D1-R1 cells do not appear to exhibit aberrant RXRb protein expression (Figure 3) . A similar low level of RXRb protein expression was detected in NT2/D1 and NT2/D1-R1 cells and was unchanged by RA-treatment. The lack of RXRb mRNA and protein induction after RA-treatment of NT2/D1 cells is consistent with a published report (Segars et al., 1993) .
Dual over-expression of RARg and RXRb in NT2/D1 cells
Since over-expression of RARg or RXRb individually signaled maturation of NT2/D1 cells that diered from that seen after RA-treatment, the consequence of combined over-expression of these receptors was studied. Ebo-RXRb transfected NT2/D1 cells described above and maintained at low dose (20 mg/ml) hygromycin B were transfected with a second episomal construct, Rep9-RARg containing the G418 resistance gene, allowing dual expression of both vectors. Marked and rapid growth suppression and morphologic maturation reminiscent of the RA-mediated neuronal phenotype was repeatedly observed when RARg and RXRb co-transfected cells were selected in both G418 and hygromycin B (Figure 4 ). Control cells transfected with Ebo and pRep9 insertless vectors had unchanged morphology and could be continuously passaged after identical selection conditions. The neuronal phenotype of RXRb/RARg co-transfectants was distinct from the observed phenotype obtained when each receptor was transfected independently (Figure 4 ). RXRb transfectants failed to exhibit a mesenchymal immunophenotype (data not shown), previously shown to be expressed after RARg over-expression (Moasser et al., 1995) . Reverse-transcription (RT) ± PCR analysis using primers speci®c for exogenous transcripts (see Materials and methods) con®rmed the expression of the desired retinoid receptors in these transfected cells ( Figure 5 ). Neuronal maturation of RXRb/RARg cotransfectants was con®rmed by immunophenotypic analysis which revealed the presence of the A2B5 surface antigen previously observed only after 9-cis retinoic acid-or RA-treatment of NT2/D1 cells (Kurie et al., 1993) . Results summarizing the growth properties and A2B5 neuronal marker analysis of NT2/D1 transfectants are presented in Table 1 . RARg and RXRb individual transfectants were immunophenotyped 4 ± 6 weeks after hygromycin B dose escalation. RXRb/RARg co-transfectants were immunophenotyped 1 ± 2 weeks after hygromycin dose escalation since these cells markedly growth arrested soon thereafter. RA treatment of NT2/D1 cells was for 5 days.
Transient transfection of RARg and RXRb in NT2/D1 cells
Prior work from this and other laboratories revealed that expression of FGF4, a member of the ®broblast 0  0  6  6  24  24  48  48  72  72  96 96 Hours RA Figure 3 Western analysis depicting the time course of RAmediated induction of RARg in NT2/D1 cells and basal expression of RXRb in NT2/D1 and NT2/D1-R1 cells. The speci®city for the RXRb band was con®rmed by the ability of an RXRb peptide to block appearance of the immunoreactive species
Control
RAR γ RXR β RAR γ + RXR β RT ± PCR analysis of NT2/D1 transfectants. PCR primers speci®c for exogenous Ebo-RXRb transcripts were used in lanes 1 ± 3 and primers speci®c for exogenous Rep9-RARg speci®c transcripts were used in lanes 4 ± 6 (described in Materials and methods). Lanes 1 and 4 are NT2/D1 cells co-transfected with both insertless Ebo and insertless pRep9 vectors. Lanes 2 and 5 are NT2/D1 cells transfected with Ebo-RXRb and lanes 3 and 6 are NT2/D1 cells co-transfected with Ebo-RXRb and Rep9-RARg growth factor family, is tightly linked to the dierentiation state of human and murine teratocarcinoma (Miller et al., 1994; Tiesman and Rizzino, 1989; Yuan et al., 1995; Yoshida et al., 1988) . This laboratory previously reported the adaptation of a transient transfection reporter assay useful to assess the role of retinoid receptors in signaling dierentiation of parental NT2/D1 cells (Moasser et al., 1994) . This assay uses a construct containing FGF4 human promoter-enhancer elements linked to the CAT reporter gene (Yuan et al., 1995) . Down-regulation of FGF4 mRNA and protein expression is tightly linked to RA-induced dierentiation and growth suppression of murine and human embryonal carcinoma cells and appears to occur`down-stream' of direct retinoid receptor-driven transactivation in this dierentiation program (Miller et al., 1994; Tiesman and Rizzino, 1989; Yuan et al., 1995; Yoshida et al., 1988) . As depicted in Figure 6a , FGF4 reporter activity decreased after RA-treatment in a dose dependent manner in NT2/D1 cells. It is known that FGF4 gene expression declines after RA-treatment of NT2/D1 cells but not NT2/D1-R1 cells (data not shown and Miller et al., 1994) . The FGF4 reporter was constitutively active in NT2/D1-R1 cells despite RA-treatment (Figure 6a) . In contrast, a reporter with the RARE containing promoter of RARb was activated in a similar RA-dependent manner in both of these embryonal carcinoma cell lines (Figure 6a) , consistent with the similar ability of RA to induce endogenous RARb expression in both cell lines (Kurie et al., 1993; Moasser et al., 1996) . Thus, FGF4 promoter-enhancer reporter activity proved to be a much more reliable marker of retinoid mediated dierentiation in this cell system than transcriptional activation of an RARE containing reporter.
All six retinoid receptors were individually assessed for the ability to repress FGF4-CAT transcriptional activity in the presence and absence of RA. An RA concentration of 1 mM was chosen since this provided a submaximal repression of FGF4 transcriptional activity in NT2/D1 cells. As shown in Figure 6b and c only RARg and RXRb substantially augmented the repression of this reporter activity, although a slight but signi®cant transcriptional repression was seen with RARb. When co-transfected, these two retinoid receptors repressed CAT activity more than either alone (Figure 6b ). This additive eect was not seen with RARa/RXRb or RARg/RXRa co-transfectants (data not shown), indicating the observed eects depended on both RARg and RXRb expression. It is notable that eects were seen in the presence of serum without addition of exogenously added RA but were augmented by RA-treatment. These ®ndings provide further evidence for an important role played by RARg and RXRb in the RA response of NT2/D1 cells.
Discussion
Elucidating the mechanisms that underlie retinoid signaling pathways remains a major challenge in the ®eld of induced tumor cell dierentiation and will require identi®cation of RA-responsive target genes. The RARs and RXRs are highly conserved in evolution and display distinct expression patterns during development and in normal and neoplastic tissues (reviewed in Mangelsdorf et al., 1994) . This suggests each receptor exerts distinct physiologic functions. Thus, one approach towards identifying target genes is to ®rst highlight which retinoid receptors are responsible for mediating speci®c Consequences of retinoid receptors on FGF4 transcription. (a) The eect of the indicated RA dosages on CAT activity of the FGF4 promoter-enhancer or luciferase activity of a RARb2-LUC reporter in NT2/D1 cells. These data were normalized to no RA or 10 75 M RA for FGF4-CAT and RARb2-LUC, respectively. The averages of two independent experiments are depicted. (b) The eect of RARg and RXRb cotransfection on FGF4 promoter-enhancer activity. RARg and RXRb were transfected individually or in combination with the FGF4-CAT plasmid into NT2/D1 cells in the presence or absence of 1 mM RA. The average results from four independent experiments are depicted. (c) The eect of transfection of dierent retinoid receptor expression plasmids on FGF4 promoter-enhancer activity in NT2/D1 cells. The RA concentration used was 1 mM. The average results from three independent transfection experiments are provided. All transfections were performed using equal amounts of reporter and expression vectors and the same total amounts of DNA. All results were ®rst corrected for b-galactosidase, as described in Material and methods. Error bars are s.d. *P value50.05; **P value50.005. phenotypic changes in de®ned RA-responsive tumor cell dierentiation models. This study addresses the contributions of speci®c retinoid receptors to RAmediated dierentiation and growth suppression in the multipotent human embryonal carcinoma cell line, NT2/D1. Prior work reveals that increased expression of RARg but not RARa or RARb signals terminal dierentiation of NT2/D1 cells (Moasser et al., 1995) . A role for other retinoid receptors in signaling tumor cell dierentiation appeared likely since the phenotype of RARg over-expressing cells diers from that of RAtreated NT2/D1 cells, as noted by the absence of neuroectodermal maturation marker induction (Moasser et al., 1995) .
The present study highlights RXRb as playing an important role along with RARg in signaling dierentiation of NT2/D1 cells. The ®ndings reported here indicate that: (1) stable transfection of RXRb but not RXRa or RXRg causes growth suppression and reduced expression of the embryonal immunophenotypic marker, SSEA3; (2) co-transfection of RARg and RXRb signals neuronal morphologic changes and induced expression of the neuroectodermal marker A2B5 while causing marked anti-proliferative eects; and (3) transient transfection assays performed with RARg and RXRb have at least additive eects in regulating the transcription of FGF4, a gene tightly linked to dierentiation states of murine and human embryonal carcinoma cells (Miller et al., 1994; Yoshida et al., 1988; Tiesman and Rizzino, 1989; Yuan et al., 1995) .
Since it was anticipated over-expression of RXRs would result in growth suppression of NT2/D1 cells, a stable episomal vector-based transfection strategy was used, as shown in Figure 1 . These EBV-based episomal vectors can replicate extrachromosomally and cDNA expression is responsive to the degree of selective pressure applied (Moasser et al., 1995; Ahn et al., 1995a,b) . This strategy was successfully employed to assess the growth suppressive and maturation eects of RARg in NT2/D1 cells when conventional stable transfection approaches failed to express potential growth suppressive cDNAs (Moasser et al., 1994 (Moasser et al., , 1995 . The conclusion in this study that RXRb mediates growth suppression in human embryonal carcinoma cells is supported by others reporting the inability to produce stable RXRb transfectants in NT2/ D1 and P19 cells . Thus, this episomal vector-based approach may provide a general strategy in addition to inducible promoter systems to characterize the eects of growth suppressive species in NT2/D1 and perhaps other tumor cells.
Although the importance of RAR/RXR heterodimerization in RA-mediated transcriptional activation is recognized, involvement of speci®c receptors has been de®ned in few cellular contexts. In vitro studies suggested that RARs and RXRs dierentially activate distinct RAREs (Nagpal et al., 1992; La Vista-Picard et al., 1996) . A recent study of the eects of selective synthetic retinoids on wild-type murine F9 embryonal carcinoma cells versus lines engineered to be devoid of speci®c retinoid receptors demonstrated distinct RAR/ RXR heterodimers mediate the expression of dierent sets of RA-responsive species (Chiba et al., 1997) . The present study supports and extends these ®ndings in murine embryonal cancer cells by performing gain of function experiments in human embryonal cancer cells. Neuronal dierentiation was only seen in RARg/ RXRb co-transfection experiments. The eects of RXRb are particularly interesting since endogenous RXRb expression was not shown to be induced by RA treatment as is the case for RARg. One interpretation of these ®ndings is that RXRb heterodimerizes with RARg during retinoid mediated dierentiation of NT2/ D1 cells and that overexpression of each dimerization partner increases their transactivation eciency in low levels of serum retinoids.
The role of individual retinoid receptors in RAmediated dierentiation of embryonal carcinoma cells may be tumor cell line dependent. A derived clone of murine P19 embryonal carcinoma cells carrying a dominant-negative form of RARa was found resistant to RA-treatment (Costa and McBurney, 1996; Pratt et al., 1990) while inactivation of RARa and RARg by homologous recombination in murine F9 teratocarcinoma cells indicated a more important role for RARg than for RARa in RA-mediated dierentiation (Boylan et al., 1994) . The importance of RXRb in murine embryonal carcinoma cell dierentiation was shown using a truncated RXRb, acting in a dominantnegative fashion, that inhibits RA-responsive gene regulation in P19 cells . Other studies using RXRa null mutants concluded that RARg/RXRa heterodimers play a major role in signaling F9 teratocarcinoma dierentiation (Cliord et al., 1996) . This apparent discordance in the role of distinct retinoid receptors in RA-mediated differentiation of dierent embryonal carcinoma cells does not preclude the possible convergence of common downstream signaling pathways of these retinoid receptors. Noteworthy is the ®nding that RARb appears to play a minor role in retinoid signaling of dierentiation based on the observation that derived or genetically engineered RA-resistant NT2/D1, F9, P19 and PCC4.aza1R embryonal carcinoma cells all retain unaltered RA-induction of RARb (Moasser et al., 1996; Kurie et al., 1993; Boylan et al., 1994; Pratt et al., 1990; Mills et al., 1996) . RA-mediated differentiation is a complex and multi-step process likely involving the coordination of many transcription factors. Although the data presented here supports the view that RARg/RXRb heterodimers play a central role in neuronal dierentiation of NT2/D1 cells, the fact that these cells abundantly express several retinoid receptor types (Moasser et al., 1995 (Moasser et al., , 1996 as well as orphan nuclear receptors (Lei et al., 1997) suggests other receptors contribute to the dierentiation phenotype.
Our results are consistent with the growing line of evidence that RAR/RXR heterodimers are the functional units mediating RA signals during embryonal carcinoma dierentiation (Chiba et al., 1997; Minucci et al., 1994 Minucci et al., , 1997 Roy et al., 1995; Horn et al., 1996; Segars et al., 1993; Cliord et al., 1996; Dey et al., 1994) . Whether RXR is required to be liganded or functions as a`silent partner' of liganded RAR is still unclear. Several reports demonstrate RXR selective ligands fail to signal dierentiation in several tumor cell lines including NT2/D1 (Roy et al., 1995; Angulo et al., 1995; Minucci et al., 1997; Horn et al., 1996) . However, recent studies using sub-optimal dosages of RAR and RXR selective ligands report synergistic induction of embryonal carcinoma dierentiation (Minucci et al., 1997; Roy et al., 1995; Horn et al., 1996) . Further studies using selective retinoids are needed to con®rm the importance of RARg and the ligand occupancy requirement of RXRb in mediating dierentiation of NT2/D1 cells.
That growth inhibition and maturation responses were observed in these transfectants without exogenous addition of retinoids can be accounted for by several explanations. These eects can be mediated by physiologic concentrations of retinoids present in serum and cells or alternatively the eects could be ligand independent. Retinoid receptors contain a putative ligand independent transactivation domain (AF1) (Mangelsdorf et al., 1994; Chambon, 1996) . Recent reports indicate that ligand is not required for some retinoid receptor functions such as heterodimerization and DNA binding (Nagpal et al., 1993) , although the existence of opposite ®ndings demonstrates that the precise role of ligand in retinoid receptor function needs to be de®ned . Based on the overwhelming evidence establishing the requirement of ligand-dependent transactivation function for retinoid receptor signaling, it is perhaps more likely that endogenous stores of retinoids within the cells or serum are activating the retinoid receptors expressed at relatively high levels as in these described transfectants. Embryonal carcinoma cells are known to have high levels of cytosolic retinoic acid binding proteins (Jetten and Jetten, 1979) and the growth medium used in this study was con®rmed by HPLC analysis to contain endogenous retinoids (Moasser et al., 1995) . A low level conversion of retinol to RA has been detected in murine F9 embryonal carcinoma cells (Williams and Napoli, 1985) . Retinol has also been reported to mediate neuronal dierentiation of F9 and NT2/D1 cells but requires much higher doses than RA (Williams and Napoli, 1985; Andrews et al., 1986) .
In this study, a novel transient transfection reporter assay employing the FGF4 promoter enhancer was further characterized (Moasser et al., 1994) . FGF4 is a member of the ®broblast growth factor family. FGF4 expression declines upon RA-treatment of NT2/D1 cells but not dierentiation resistant human teratocarcinomas (Miller et al., 1994) and this decline is required for the RA-mediated decline in NT2/D1 cellular tumorigenicity as judged by engineered over-expression studies (E Dmitrovsky, unpublished results). Prior studies in F9 murine teratocarcinoma cells and human embryonal carcinoma cells indicate that FGF4 expression is down-regulated by RA-treatment and is linked to the state of embryonal carcinoma dierentiation (Miller et al., 1994; Yoshida et al., 1988; Tiesman and Rizzino, 1989; Yuan et al., 1995) . The mechanism for this RA-mediated decline is complex and is indirectly mediated by retinoid receptors. There are no RARE motifs in the RA-responsive enhancer region of FGF4, however binding sites for the embryogenesis stage speci®c transcription factors Oct3/4 and Sox2 are present (Yuan et al., 1995) . Oct3/4 is rapidly downregulated after RA-treatment of embryonal carcinoma cells through an interplay between negative and positive responsive elements speci®c for several members of the nuclear receptor family including retinoid receptors (Schoorlemmer et al., 1994; BenShushan et al., 1995) . The mechanisms controlling the regulation of the recently identi®ed Sry-related Sox family of transcription factors have not been fully elucidated (reviewed in Pevny and Lovell-Badge, 1997) . However, the pattern of Sox2 expression during neuronal development is tightly regulated with a rapid down-regulation of Sox2 expression seen during dierentiation of neuronal precursors in both the mouse and chick (Uwanogho et al., 1995; Collignon et al., 1996) .
Thus, the FGF4 decline during retinoid treatment of embryonal carcinoma cells is part of a complex dierentiation cascade that appears to be initiated by, but down-stream of, retinoid receptor activation. The FGF4 reporter activity decreased in an RA dose-dependent manner in NT2/D1 cells but not in its RA-resistant clone NT2/D1-R1. This demonstrates that transcriptional activity is tightly linked to the NT2/D1 dierentiation state (Figure 6a ). By comparison, an RARb promoter that is directly activated by retinoid receptors via the RARE D5 motif was active in a similar manner in both retinoid sensitive and resistant lines, before and after RA-treatment. This FGF4 promoter-enhancer co-transfection assay is used in this study to provide further evidence that RARg and RXRb preferentially induce dierentiation in NT2/D1 cells. Although the exact mechanism of RA-regulated FGF4 expression awaits further study, this reporter assay may prove useful to rapidly assess the maturation eects of candidate target genes signaling human embryonal carcinoma dierentiation.
In summary, this study reports that RXRb mediates growth suppression of human embryonal carcinoma cells and with RARg cooperates to signal neuronal dierentiation. It is notable over-expression of RARa, RARb, RXRa, or RXRg each fail to signal growth suppression or maturation of these cells. Since cooperation between RARg and RXRb is observed both in transient and stable transfection assays, this strongly argues that these heterodimers preferentially signal the RA-mediated eects in this tumor cell model. Future work using RARg and RXR selective ligands should extend these gain of function studies to learn whether cooperation also occurs during induced dierentiation by ligand-dependent activation of these retinoid receptors.
Materials and methods
Cell culture and proliferation assay NT2/D1 and NT2/D1-R1 (a derived RA resistant subclone of NT2/D1) (Moasser et al., 1996) cells were cultured in Dulbecco's Modi®ed Eagle's Media (DME) with 10% FBS, 20 mM glutamine, 100 U/ml penicillin, 200 mg/ml streptomycin as previously described (Kurie et al., 1993; Miller et al., 1990) . To assess for induced dierentiation of parental NT2/D1 cells or NT2/D1 transfectants 10 6 cells were seeded per 10 cm plate with or without 10 mM RA. The emergence of the neuronal phenotype was studied 5 days later by the appearance of established immunophenotypic antigens. Transfectants were maintained under selection in G418 and/or hygromycin B throughout the analysis. Cell growth was quanti®ed by the MTT proliferation assay using established techniques.
Immunophenotypic analysis
Indirect¯ow cytometry analysis (FACS) was performed as previously described (Kurie et al., 1993) . Brie¯y, NT2/D1 cells and indicated transfectants were harvested with trypsin and incubated with antibodies to cell surface antigens recognized by SSEA3 (Fenderson et al., 1987) , A2B5 (Andrews, 1984) , and with isotype matched monoclonal antibodies as controls. A2B5 antibody was prepared from hybridoma cultures purchased from ATCC and SSEA3 antibody was purchased from the Developmental Studies Hybridoma Bank (University of Iowa). Cells were indirectly assayed with FITC-conjugated goatanti mouse antibody and¯uorescence was measured as described (Kurie et al., 1993) . Mean peak¯uorescence values as well as percentage of positive cells were measured in the entire population. RA treatments where indicated were for 5 days at a concentration of 10 mM.
Construction of expression vectors
Eboplpp (Ebo) is an SV40 driven expression vector containing the hygromycin resistance gene for selection. To construct Ebo-RXRb and Ebo-RXRg expression plasmids, full length human RXRb (Leid et al., 1992b) and murine RXRg (Mangelsdorf et al., 1992) cDNAs were excised from their respective vectors, blunt ended, and cloned into the SacI site of Ebo. pRep9 (Invitrogen) is an RSV LTR driven expression vector containing the G418 resistance gene for selection. Rep9-RARg was constructed by inserting the full length cDNA of human RARg1 (Krust et al., 1989) into HindIII and XhoI cut pRep9. The construction of Ebo-RXRa has been previously described (Moasser et al., 1995) . Expression plasmids containing RARa1, RARb2, and RARg1 in PSG5 were kindly provided by Dr P Chambon, INSERM, France.
Stable transfections
Transfections were performed using a modi®ed CaPO 4 technique and established techniques as previously described (Kurie et al., 1993; Moasser et al., 1995) . Following overnight incubation with Ebo insertless, EboRXRa, Ebo-RXRb, or Ebo-RXRg containing DNA precipitates, NT2/D1 cells were cultured in the described media for 48 h before hygromycin B selection. After 1 ± 2 months of selection at low dose (20 ± 50 mg/ml) hygromycin B, transfectants were then subjected to high dose (250 ± 500 mg/ml) hygromycin B.
For co-transfection experiments, Ebo-RXRb transfected NT2/D1 cells maintained at low dose hygromycin B were transfected with pRep9 or Rep9-RARg expression plasmids and selected at high dose 250 mg/ml hygromycin B and 200 mg/ml G418 for 1 ± 2 weeks. Controls were NT2/D1 cells transfected only with pRep-RARg (selected in G418 only) and NT2/D1 cells co-transfected with Ebo and pRep9 insertless vectors.
Western and Northern analysis
For Western analysis, exponentially growing cells were lysed in a modi®ed RIPA buer (10 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, 50 mM NaF, 1.1 mM Na 3 Vo 4 , 1.0% Triton X-100, 24 mg/ml aprotinin, 2.5 mg/ml leupeptin, 2.5 mg/ml antipain, 250 mg/ml PMSF¯uoride, 1.0% sodium deoxycholate and 0.1% SDS). Protein concentrations were determined using the Bradford technique. Total cellular proteins (100 mg) were analysed by SDS ± PAGE, transferred to nitrocellulose ®lters by wet electrotransfer and incubated with the desired primary antibody. Detection was by enhanced chemiluminescence (Amersham). RARg (C-19) and RXRb (C-20) polyclonal antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA) and used at a 1:200 dilution. Speci®c bands were of the expected size and were con®rmed to be the desired species by blocking with blocking peptides provided by the supplier. Total cellular RNA (10 mg) was puri®ed using guanidine thiocyanate and subjected to Northern analysis as previously described (Miller et al., 1990) . A human RXRb probe was generated by random priming of a full length cDNA fragment.
RT ± PCR analysis
Total RNA was isolated from 10 7 cells using Trizol (Life Technologies, Inc./BRL) and resuspended in sterile water. Using 15 mg total RNA in a ®nal volume of 30 ml ®rst strand synthesis was performed with random hexamers using Superscript RT (Stratagene). To exclusively detect exogenous transcripts, a 1.2 kb product for Ebo-RXRb and a 0.3 kb product for Rep9-RARg transfectants were generated from the products of the ®rst strand synthesis by ampli®cation utilizing sense oligonucleotide primers speci®c for the 5' polyclonal region downstream of the transcription start site of the Ebo (5'-CTTCTGCTC-TAAAAGCTGCGTAC-3') or pRep9 (5'-TGCACCTCCA-AGCTGGGTACC-3') vectors, respectively. Antisense oligonucleotide primers were speci®c for human RXRb (5'-AGCTGTCTGGGCTTCGGGAGT-3') or for human RARg (5'-ATCTCCTCTGAGCTGGTGCTCT-3'). A 2 ml volume of the ®rst stand synthesis product was ampli®ed in 10 mM KCl, 20 mM Tris-HCl (pH 8.8) 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100, 300 mM of each deoxyribonucleotide, 0.4 mM each primer and 0.5 units of Taq DNA polymerase (Fisher) in a 20 ml reaction volume. Following an incubation of 2 min at 958C, ampli®cation was carrier out for 35 cycles of 30 s at 958C, 30 s at 588C and 1 min at 728C. Products were size-fractionated on a 1% agarose gel.
Transient transfection assay
Transient transfection of NT2/D1 and NT2/D1-R1 cells has been previously described (Kurie et al., 1993; Moasser et al., 1994) . Brie¯y, cells were transfected with 10 mg DNA including 4 mg reporter plasmid, 2.5 mg expression plasmid and 1.0 mg of a CMV driven b-galactosidase expression plasmid using a modi®ed calcium phosphate precipitation technique. PSG5-based expression plasmids were used for RARa, RARb and RARg and Ebo-based expression plasmids were used for RXRa, RXRb and RXRg transfections, as described above. Co-transfected expression plasmids were each used at 2.5 mg. PSG5 insertless vector was used to normalize DNA content in transfections.
The FGF ± CAT construct contains a human RA-sensitive FGF4 enhancer placed within a CAT containing reporter driven by the endogenous human FGF4 promoter (Yuan et al., 1995) . The RARb 2-LUC plasmid contains a 220 bp segment of the human RARb 2 promoter, which includes RAREs, subcloned into a promoterless luciferase reporter plasmid, P19LUC (Kruyt et al., 1991) . All plates transfected with a given plasmid combination received a portion of the same calcium phosphate precipitate. Cells (8610 5 ) were exposed to DNA precipitate for 14 ± 16 h and then to a HEPES buered saline (HBS)/glycerol solution for 45 s. Cells were then washed and cultured with or without RA for an additional 48 h before harvesting in isotonic buer (150 mM NaCl, 40 mM Tris-HCl, pH 8 and 1 mM EDTA). After a brief centrifugation, cells were lysed in 100 ml of 0.25 M TrisHCl, pH 8 by three freeze/thaw cycles (dry ice-ethanol/378C). CAT and luciferase activities were measured as previously described and normalized to b-galactosidase activity (Kurie et al., 1993; Moasser et al., 1994) . The P values were obtained using the Student's t test.
